retatrutide phase 2 weight loss results Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released trial demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Lost 50lbs in 3 months!

By letting the body acclimate to new habits without overexertion, lower impact workouts maintain a low injury risk

Erectile dysfunction is a common problem that affects men of all ages and is a big contributor to low libido

The pervasive stereotype that plagues folks in larger bodies is that fast food and ultra-processed foods are to blame

Retatrutide is an investigational drug, still undergoing clinical trials and not yet approved for medical use or prescription in the European Union

Technique : Wipe the injection area with alcohol beforehand, always use a new needle, and press the medication in

Comparable to other peptides linked to fatty acids (e.g., the insulins detemir and degludec, the GLP-1RA liraglutide and semaglutide), the fatty acid side chain allows binding to albumin after subcutaneous injection, slows enzymatic degradation and prolongs biological half-life (5760)